The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.
The conjunctival surface hosts fewer microbial species relative to adjacent skin areas. Dominant taxa include Staphylococcus epidermidis, Cutibacterium acnes (formerly Propionibacterium acnes), and various Corynebacterium species. Blinking mechanically clears microbes from the ocular surface, while tear fluid, enriched with antimicrobial peptides (e.g., lysozyme, lactoferrin, and defensins), imposes selective pressure on microbial colonization. These defenses contribute to the ocular surface's low microbial diversity.
On the other hand, the eyelid margins and meibomian glands show higher microbial diversity. These areas are in direct contact with the skin and secrete lipid-rich substances that support a broader range of microorganisms. The microbial inhabitants here are more reflective of cutaneous communities and include both commensal and opportunistic species.
The ocular microbiota contributes to immune modulation and pathogen exclusion. It interacts with innate immune receptors on epithelial and immune cells, helping to calibrate inflammatory responses. Disruptions to this equilibrium, whether through antibiotic use, environmental factors, or systemic conditions, have been implicated in ocular disorders such as blepharitis, conjunctivitis, and dry eye disease. Invasive microbial entry into intraocular compartments, typically sterile, can occur following surgical interventions, trauma, or the presence of foreign bodies, potentially leading to severe infections like endophthalmitis.
Understanding the composition and function of the ocular microbiota offers insights into novel diagnostic and therapeutic strategies for maintaining ocular health and managing microbiota-associated diseases.
The surface of the human eye hosts a low-biomass microbiota, mainly found on the conjunctiva.
The dominant bacterial genera include Staphylococcus, Cutibacterium, and Corynebacterium.
Compared to the surrounding eyelid skin, the conjunctiva supports fewer microbial species.
Constant blinking physically removes and washes away microbes. Additionally, tears contain antimicrobial proteins and enzymes that inhibit microbial growth.
The eyelid margins and meibomian glands host a more diverse microbiota due to their connection with the skin and sebaceous secretions.
Although intraocular regions are typically sterile, microorganisms may gain access if ocular barriers are compromised, such as during surgery or trauma.
The ocular microbiota plays a protective role by occupying ocular surface niches, thereby limiting pathogen colonization.
Disruptions in the eye microbiota have been associated with conditions such as blepharitis, dry eye disease, and conjunctivitis, which are multifactorial and not caused solely by microbiota changes.
繁體中文
